Femasys Inc. Files 8-K Report
Ticker: FEMY · Form: 8-K · Filed: Jun 20, 2024 · CIK: 1339005
| Field | Detail |
|---|---|
| Company | Femasys Inc (FEMY) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Femasys filed an 8-K, check for updates.
AI Summary
On June 20, 2024, Femasys Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and operational events. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing signals that Femasys Inc. is providing updated information to the SEC, which could include material events or financial disclosures relevant to investors.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification without specific details of negative events, thus posing a low immediate risk.
Key Players & Entities
- FEMASYS INC (company) — Registrant
- 0001339005 (company) — Central Index Key
- DE (company) — State of Incorporation
- GA (company) — State of Business Address
- 30024 (company) — Zip Code of Business Address
- 770-500-3910 (company) — Business Phone Number
FAQ
What is the primary purpose of this 8-K filing for Femasys Inc.?
The filing indicates "Other Events" and "Financial Statements and Exhibits," suggesting it's for reporting material events or financial updates.
When was this 8-K report filed?
The report was filed on June 20, 2024.
What is Femasys Inc.'s state of incorporation?
Femasys Inc. is incorporated in Delaware (DE).
What is Femasys Inc.'s principal executive office address?
The principal executive offices are located at 3950 Johns Creek Court, Suite 100, Suwanee, Georgia 30024.
Does the filing excerpt detail any specific new financial information or material events?
No, the provided excerpt does not detail specific financial figures or new material events; it only indicates the categories of information being reported.
Filing Stats: 456 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-06-20 08:49:26
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share FEMY The Nasdaq Stock Mar
Filing Documents
- ef20031386_8k.htm (8-K) — 31KB
- ef20031386_ex99-1.htm (EX-99.1) — 12KB
- 0001140361-24-030638.txt ( ) — 185KB
- femy-20240620.xsd (EX-101.SCH) — 4KB
- femy-20240620_lab.xml (EX-101.LAB) — 22KB
- femy-20240620_pre.xml (EX-101.PRE) — 16KB
- ef20031386_8k_htm.xml (XML) — 4KB
01
Item 8.01 Other Events On June 20, 2024, Femasys Inc. (the "Company") issued a press release announcing receipt of CE Mark approval for four of its women's health products, clearing the path for the company to begin commercialization efforts in Europe. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Femasys Inc. dated June 20, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Femasys Inc. By: /s/ Kathy Lee-Sepsick Names: Kathy Lee-Sepsick Title: Chief Executive Officer Date: June 20, 2024